Partnerships
Your medicine, made here.
A licensed sterile plant in Pakistan that has already made infusions for B. Braun, under their brand and to their specification.
Capability
Container and volume
- Medical-grade polypropylene
- Bottle formed on site
- 5 ml to 1 litre
- Small- and large-volume parenterals
Process
- Terminal sterilization, 121°C
- Sterilized in the sealed final container
- Water for Injection on the line
- Aqueous solutions
Scale
- 61.7 million units, FY2025–26
- In production since 2008
- Small lots accepted
- One line, one product at a time
The site
- Licence
- DML 000633 · formulation · DRAP
- Site
- Plot 18/3, Phase-I, Hattar Industrial Estate, Haripur
- In production since
- 2008
- Fill volumes
- 5 ml – 1,000 ml
- Container
- Medical-grade polypropylene, formed on this site
- Sterilization
- Terminal, 121°C, in the sealed final container
- Water
- Water for Injection, pharmacopoeial grade
- Output
- 61.7 million units, FY2025–26
- Markets
- Pakistan nationwide, and export
- Release testing
- Sterility, endotoxin, particulates and content, on site
Prior experience
B. Braun chose this plant.
Ten of their products were contract-manufactured at this plant.
NS, DS, DS ½, RL, RLD, G5, G10, Paeds, Mannitol, and Ecoflac Plus NS. Made at this plant from 2014 to 2020.
Direction
Where this plant goes next.
Sterile products beyond fluids
The same water system, the same autoclave, the same laboratory, carrying forms this site does not fill yet.
Medicines Pakistan does not make
Bringing manufacture of hospital medicines that are imported today, or not available here at all, onto this licence.
Development on site
Formulation and analytical work done here rather than bought in, so a partner’s transfer has somewhere to land.
These are live programmes, and a partner who joins now helps shape them. Everything above this line is already running.
Joint ventures
Where we want a partner.
- Critical care and clinical nutrition
- Nephrology
- Oncology
- Infectious disease
How a deal is shaped
Licence
You own the registration; we manufacture to it.
Technology transfer
Your process, qualified onto this line and this licence.
The structure follows the medicine.